Under the agreement, Inceptus will use MicroBraid technology in select medical device applications.

The agreement also allows Inceptus to utilize MicroBraid technology in several new product opportunities where the proprietary technology may provide clinical advantages.

Inceptus Medical president Bob Rosenbluth said the company plans to apply MicroBraid technology to cardiovascular applications for which the fine pore structure of the technology may provide clinical benefits in occlusion and healing.

Sequent said its WEB aneurysm embolization system utilizes MicroBraid technology in the treatment of cerebral aneurysms.